Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nepsilon-(4-methyltrityl)-L-lysine>98.0%(HPLC)(N)5g

Perindopril Erbumine>98.0%(HPLC)(T)200mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylhept-6-enoic acid, 95.0%, 10g

7-CHLOROQUINOLINE-5-CARBOXYLIC ACID, 95.0%, 100mg

2-Ethylthiazole>98.0%(GC)(T)5g

N,N-diethyl-N'-(4-methoxy-1,3-benzothiazol-2-yl)ethane-1,2-diamine, 95.0%, 500mg

(1R)-1-(2-CHLORO-3-FLUOROPHENYL)ETHYLAMINE, 95.0%, 250mg

4-BROMO-1,3-DIHYDROISOBENZOFURAN, 95.0%, 1g

2,6-Dichloroquinoxaline>98.0%(GC)5g

2-(2-(Benzyloxy)-5-(tert-butyl)phenyl)-2-methylpropanenitrile, 95.0%, 100mg

(R)-methyl 2-(3,5-difluorophenyl)-2-hydroxyacetate, 95%, 100mg

2,4,6-Triphenylpyrylium tetrafluoroborate, 95.0%, 10g

Recipiente di reazione a flangia piatta, cilindrico, graduato, con camicia di rinvenimento e sottovuoto e valvola di scarico, DN 100, 3000 ml, 250 mm, 1 Pezzo